Non-Peptide Arginine-Vasopressin Antagonists (Vaptans) for the Treatment of Hyponatremia in Neurocri...
Non-Peptide Arginine-Vasopressin Antagonists (Vaptans) for the Treatment of Hyponatremia in Neurocritical Care: A New Alternative?
About this item
Full title
Author / Creator
Publisher
New York: Humana Press Inc
Journal title
Language
English
Formats
Publication information
Publisher
New York: Humana Press Inc
Subjects
More information
Scope and Contents
Contents
[...]inappropriate release of AVP may occur in association with a variety of neoplasms and drugs, as well as with diseases affecting the central nervous system, peripheral nervous system, or lungs [7]. Because of its fundamental role in increasing free water resorption by the kidney (thereby decreasing plasma osmolality), antagonism of the V2 recep...
Alternative Titles
Full title
Non-Peptide Arginine-Vasopressin Antagonists (Vaptans) for the Treatment of Hyponatremia in Neurocritical Care: A New Alternative?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_746205923
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_746205923
Other Identifiers
ISSN
1541-6933
E-ISSN
1556-0961
DOI
10.1007/s12028-009-9224-x
